Merck & Co., Inc. logo
Merck & Co., Inc. (MRK)
Compare

Merck & Co., Inc. (MRK) Free Cash Flow Yield: 4.82%

Is Merck & Co., Inc.’s free cash flow yield high or low?

Merck & Co., Inc.'s free cash flow yield of 4.82% is in line with its 5-year average of 5.04%, around the middle of its 5-year range (2.42%–9.31%).

The free cash flow yield for Merck & Co., Inc. (MRK) is 4.82% as of Wednesday, June 10, 2026. It is below its 12-month average by 17.59% (5.85%).

MRK Free Cash Flow Yield Chart

MRK Free Cash Flow Yield
4.82%-41.79% 1Y
Zoom

MRK Average Free Cash Flow Yield Chart

MRK Current vs Average Free Cash Flow Yield Chart

MRK Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

4.82%

FREE CASH FLOW YIELD AVG TTM

5.85%

FREE CASH FLOW YIELD AVG 3Y

5.24%

FREE CASH FLOW YIELD AVG 5Y

5.04%

FREE CASH FLOW YIELD AVG 10Y

4.69%

FREE CASH FLOW YIELD AVG 15Y

5.36%

FREE CASH FLOW YIELD AVG 20Y

5.67%

CURRENT VS TTM AVG

-17.59%

CURRENT VS 3Y AVG

-7.96%

CURRENT VS 5Y AVG

-4.39%

CURRENT VS 10Y AVG

+2.85%

CURRENT VS 15Y AVG

-10.09%

CURRENT VS 20Y AVG

-15.02%

MRK Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
Merck & Co., Inc. (MRK)4.82%5.85%5.24%5.04%
UnitedHealth Group Incorporated (UNH)$368.44B5.32%7.02%5.44%5.29%
AbbVie Inc. (ABBV)$399.54B5.21%4.95%6.33%7.32%
Amgen Inc. (AMGN)$183.75B4.65%5.90%5.48%5.88%
Thermo Fisher Scientific Inc. (TMO)$179.45B3.75%3.35%3.39%3.32%
Abbott Laboratories (ABT)$154.66B4.76%3.47%3.07%3.51%
Gilead Sciences, Inc. (GILD)$151.21B6.70%6.08%7.45%8.69%
Intuitive Surgical, Inc. (ISRG)$146.44B1.90%1.28%0.87%1.09%
Pfizer Inc. (PFE)$146.36B6.45%7.35%5.93%7.34%
Danaher Corporation (DHR)$130.25B4.03%3.49%3.47%3.67%

Yield Comparison

FCF Yield

4.82%

Earnings Yield

3.00%

Dividend Yield

2.80%

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Merck & Co., Inc. Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Merck & Co., Inc. Free Cash Flow Yield FAQ

What is the free cash flow yield for Merck & Co., Inc. (MRK)?
The free cash flow yield for MRK stock is 4.82%.
Is Merck & Co., Inc.'s free cash flow yield high or low?
Merck & Co., Inc.'s free cash flow yield of 4.82% is in line with its 5-year average of 5.04%, around the middle of its 5-year range (2.42%–9.31%).
What is the TTM average free cash flow yield for Merck & Co., Inc. (MRK)?
The TTM average free cash flow yield for MRK stock is 5.85%.
What is the 3Y average free cash flow yield for Merck & Co., Inc. (MRK)?
The 3Y average free cash flow yield for MRK stock is 5.24%.
What is the 5Y average free cash flow yield for Merck & Co., Inc. (MRK)?
The 5Y average free cash flow yield for MRK stock is 5.04%.
What is the 10Y average free cash flow yield for Merck & Co., Inc. (MRK)?
The 10Y average free cash flow yield for MRK stock is 4.69%.
What is the 15Y average free cash flow yield for Merck & Co., Inc. (MRK)?
The 15Y average free cash flow yield for MRK stock is 5.36%.
What is the 20Y average free cash flow yield for Merck & Co., Inc. (MRK)?
The 20Y average free cash flow yield for MRK stock is 5.67%.

Merck & Co., Inc. Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-104.82%
2026-06-094.77%
2026-06-084.78%
2026-06-054.73%
2026-06-044.75%
2026-06-034.98%
2026-06-024.94%
2026-06-014.96%
2026-05-294.81%
2026-05-284.76%
2026-05-274.75%
2026-05-264.77%
2026-05-224.66%
2026-05-214.93%
2026-05-205.05%
2026-05-195.00%
2026-05-185.07%
2026-05-155.13%
2026-05-145.04%
2026-05-135.03%
2026-05-125.08%
2026-05-115.13%
2026-05-085.13%
2026-05-075.08%
2026-05-065.03%
2026-05-055.05%
2026-05-045.05%
2026-05-014.43%
2026-04-304.55%
2026-04-294.48%
2026-04-284.51%
2026-04-274.51%
2026-04-244.44%
2026-04-234.33%
2026-04-224.40%
2026-04-214.41%
2026-04-204.24%
2026-04-174.17%
2026-04-164.30%
2026-04-154.21%
2026-04-144.14%
2026-04-134.13%
2026-04-104.09%
2026-04-094.05%
2026-04-084.03%
2026-04-074.16%
2026-04-064.11%
2026-04-024.11%
2026-04-014.11%
2026-03-314.13%
2026-03-304.21%
2026-03-274.15%
2026-03-264.18%
2026-03-254.16%
2026-03-244.27%
2026-03-234.29%
2026-03-204.35%
2026-03-194.35%
2026-03-184.34%
2026-03-174.29%
2026-03-164.30%
2026-03-134.30%
2026-03-124.29%
2026-03-114.28%
2026-03-104.24%
2026-03-094.24%
2026-03-064.29%
2026-03-054.28%
2026-03-044.13%
2026-03-034.15%
2026-03-024.09%
2026-02-274.01%
2026-02-264.16%
2026-02-254.06%
2026-02-244.01%
2026-02-234.22%
2026-02-204.27%
2026-02-194.29%
2026-02-184.29%
2026-02-174.30%
2026-02-134.30%
2026-02-124.38%
2026-02-114.38%
2026-02-104.46%
2026-02-094.44%
2026-02-064.28%
2026-02-054.36%
2026-02-044.42%
2026-02-034.51%
2026-02-024.61%
2026-01-304.74%
2026-01-294.82%
2026-01-284.89%
2026-01-274.84%
2026-01-264.86%
2026-01-234.83%
2026-01-224.78%
2026-01-214.70%
2026-01-204.77%
2026-01-164.80%
2026-01-154.71%
2026-01-144.71%
2026-01-134.83%
2026-01-124.78%
2026-01-094.73%
2026-01-084.71%
2026-01-074.81%
2026-01-064.80%
2026-01-054.86%
2026-01-024.91%
2025-12-314.96%
2025-12-304.93%
2025-12-294.90%
2025-12-264.89%
2025-12-244.91%
2025-12-234.97%
2025-12-224.99%
2025-12-195.17%
2025-12-185.19%
2025-12-175.27%
2025-12-165.32%
2025-12-155.21%
2025-12-125.21%
2025-12-115.28%
2025-12-105.35%
2025-12-095.39%
2025-12-085.28%
2025-12-055.24%
2025-12-045.18%
2025-12-035.11%
2025-12-025.17%
2025-12-015.13%
2025-11-284.98%
2025-11-264.99%
2025-11-254.94%
2025-11-245.20%
2025-11-215.34%
2025-11-205.50%
2025-11-195.49%
2025-11-185.42%
2025-11-175.62%
2025-11-145.62%
2025-11-135.62%
2025-11-125.71%
2025-11-115.74%
2025-11-106.02%
2025-11-076.05%
2025-11-066.09%
2025-11-056.19%
2025-11-046.99%
2025-11-037.10%
2025-10-316.81%
2025-10-306.79%
2025-10-296.77%
2025-10-286.73%
2025-10-276.66%
2025-10-246.70%
2025-10-236.72%
2025-10-226.69%
2025-10-216.68%
2025-10-206.79%
2025-10-176.91%
2025-10-166.98%
2025-10-156.96%
2025-10-146.92%
2025-10-136.84%
2025-10-106.81%
2025-10-096.69%
2025-10-086.78%
2025-10-076.69%
2025-10-066.60%
2025-10-036.57%
2025-10-026.54%
2025-10-016.50%
2025-09-306.98%
2025-09-297.46%
2025-09-267.46%
2025-09-257.55%
2025-09-247.35%
2025-09-237.33%
2025-09-227.29%
2025-09-197.19%
2025-09-187.18%
2025-09-177.22%
2025-09-167.23%
2025-09-157.23%
2025-09-127.07%
2025-09-116.88%
2025-09-106.97%
2025-09-096.93%
2025-09-086.97%
2025-09-056.92%
2025-09-046.97%
2025-09-036.96%
2025-09-026.85%
2025-08-296.96%
2025-08-287.04%
2025-08-276.97%
2025-08-266.89%
2025-08-256.87%
2025-08-226.71%
2025-08-216.81%
2025-08-206.92%
2025-08-196.90%
2025-08-186.95%
2025-08-156.96%
2025-08-147.08%
2025-08-137.08%
2025-08-127.29%
2025-08-117.32%
2025-08-087.26%
2025-08-077.29%
2025-08-067.37%
2025-08-057.25%
2025-08-048.43%
2025-08-018.49%
2025-07-318.62%
2025-07-308.24%
2025-07-298.15%
2025-07-288.01%
2025-07-257.95%
2025-07-248.01%
2025-07-238.02%
2025-07-228.25%
2025-07-218.49%
2025-07-188.42%
2025-07-178.26%
2025-07-168.17%
2025-07-158.26%
2025-07-148.05%
2025-07-118.08%
2025-07-108.01%
2025-07-098.05%
2025-07-088.27%
2025-07-078.32%
2025-07-038.32%
2025-07-028.17%
2025-07-018.23%
2025-06-308.50%
2025-06-278.51%
2025-06-268.54%
2025-06-258.45%
2025-06-248.38%
2025-06-238.40%
2025-06-208.52%
2025-06-188.49%
2025-06-178.60%
2025-06-168.31%
2025-06-138.24%
2025-06-128.23%
2025-06-118.38%
2025-06-108.28%
2025-06-098.49%
2025-06-068.53%
2025-06-058.67%
2025-06-048.60%
2025-06-038.73%
2025-06-028.83%
2025-05-308.76%
2025-05-298.81%

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.

Rahway, NJ
73,000 employees
Healthcare / Drug Manufacturers - General
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert Davis